|
1
|
Guggino G, Giardina A, Ferrante A,
Giardina G, Schinocca C, Sireci G, Dieli F, Ciccia F and Triolo G:
The in vitro addition of methotrexate and/or methylprednisolone
determines peripheral reduction in Th17 and expansion of
conventional Treg and of IL-10 producing Th17 lymphocytes in
patients with early rheumatoid arthritis. Rheumatol Int.
35:171–175. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Niu Q, Cai B, Huang ZC, Shi YY and Wang
LL: Disturbed Th17/Treg balance in patient with rheumatoid
arthritis. Rheumatol Int. 32:2731–2736. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Firestein GS: Evolving concepts of
rheumatoid arthritis. Nature. 423:356–361. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolb C, Mauch S, Peter HH, Krawinkel U and
Sedlacek R: The matrix metalloproteinase RASI-1 is expressed in
synovial blood vessels of a rheumatoid arthritis patient. Immunol
Lett. 57:83–88. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sakaguchi S, Ono M, Setoguchi R, Yagi H,
Hori S, Fehervari Z, Shimizu J, Takahashi T and Nomura T: Foxp3+
CD25+ CD4+ natural regulatory T cells in dominant self-tolerance
and autoimmune disease. Immunol Rev. 212:8–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dejaco C, Duftner C, Grubeck-Loebenstein B
and Schirmer M: Imbalance of regulatory T cells in human autoimmune
diseases. Immunology. 117:289–300. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bettelli E, Oukka M and Kuchroo VK:
T(H)-17 cells in the circle of immunity and autoimmunity. Nat
Immunol. 8:345–350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Boissier MC, Assier E, Falgarone G and
Bessis N: Shifting the imbalance from Th1/Th2 to Th17/treg: The
changing rheumatoid arthritis paradigm. Joint Bone Spine.
75:373–375. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y,
Yang X, Lian F and Sun L: Anti-malarial agent artesunate inhibits
TNF-alpha induced production of proinflammatory cytokines via
inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human
rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology
(Oxford). 46:920–926. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Y, Wang S, Wang Y, Zhou C, Chen G, Shen
W, Li C, Lin W, Lin S, Huang H, et al: Inhibitory effect of the
antimalarial agent artesunate on collagen-induced arthritis in rats
through nuclear factor kappaB and mitogen-activated protein kinase
signaling pathway. Transl Res. 161:89–98. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li B, Yu M, Pan X, Ren C, Peng W, Li X,
Jiang W, Zheng J and Zhou H: Artesunate reduces serum
lipopolysaccharide in cecal ligation/puncture mice via enhanced LPS
internalization by macrophages through increased mRNA expression of
scavenger receptors. Int J Mol Sci. 15:1143–1161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Z, Ding J, Yang C, Gao Y, Li X, Chen
X, Peng Y, Fang J and Xiao S: Immunomodulatory and
anti-inflammatory properties of artesunate in experimental colitis.
Curr Med Chem. 19:4541–4551. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mo HY, Wang LF and Zhang LH: Effects of
artesunate on tumor necrosis factor alpha and chemotactic factors
in the serum and the synoviocyte culture supernate of
collagen-induced arthritis rats. Zhongguo Zhong Xi Yi Jie He Za
Zhi. 32:253–256. 2012.(In Chinese). PubMed/NCBI
|
|
14
|
Cuzzocrea S, Mazzon E, Bevilaqua C,
Costantino G, Britti D, Mazzullo G, De Sarro A and Caputi AP:
Cloricromene, a coumarine derivative, protects against
collagen-induced arthritis in Lewis rats. Br J Pharmacol.
131:1399–1407. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Brahn E, Peacock DJ and Banquerigo ML:
Suppression of collagen-induced arthritis by combination
cyclosporin A and methotrexate therapy. Arthritis Rheum.
34:1282–1288. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mukherjee P, Yang SY, Wu B, Song Z, Myers
LK, Robbins PD and Wooley PH: Tumour necrosis factor receptor gene
therapy affects cellular immune responses in collagen induced
arthritis in mice. Ann Rheum Dis. 64:1550–1556. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American Rheumatism Association 1987 revised criteria
for the classification of rheumatoid arthritis. Arthritis Rheum.
31:315–324. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xinqiang S, Fei L, Nan L, Yuan L, Fang Y,
Hong X, Lixin T, Juan L, Xiao Z, Yuying S and Yongzhi X:
Therapeutic efficacy of experimental rheumatoid arthritis with
low-dose methotrexate by increasing partially CD4+CD25+Treg cells
and inducing Th1 to Th2 shift in both cells and cytokines. Biomed
Pharmacother. 34:463–471. 2010. View Article : Google Scholar
|
|
19
|
Durie FH, Fava RA, Foy TM, Aruffo A,
Ledbetter JA and Noelle RJ: Prevention of collagen-induced
arthritis with an antibody to gp39, the ligand for CD40. Science.
261:1328–1330. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tu Y: The discovery of artemisinin
(qinghaosu) and gifts from Chinese medicine. Nat Med. 17:1217–1220.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li T, Chen H, Wei N, Mei X, Zhang S, Liu
DL, Gao Y, Bai SF, Liu XG and Zhou YX: Anti-inflammatory and
immunomodulatory mechanisms of artemisinin on contact
hypersensitivity. Int Immunopharmacol. 12:144–150. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Dell JR, Leff R, Paulsen G, Haire C,
Mallek J, Eckhoff PJ, Fernandez A, Blakely K, Wees S, Stoner J, et
al: Treatment of rheumatoid arthritis with methotrexate and
hydroxychloroquine, methotrexate and sulfasalazine, or a
combination of the three medications: Results of a two-year,
randomized, double-blind, placebo-controlled trial. Arthritis
Rheum. 46:1164–1170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Aldieri E, Atragene D, Bergandi L, Riganti
C, Costamagna C, Bosia A and Ghigo D: Artemisinin inhibits
inducible nitric oxide synthase and nuclear factor NF-κB
activation. FEBS Lett. 552:141–144. 2003. View Article : Google Scholar : PubMed/NCBI
|
